Home
Search
BIO Digital

Speakers & Presenters

Meet the experts speaking on our world-class education program.

June 10-11 & 14-18, 2021
Search
Event Menu
Event Menu
Search General Info
Search Education
Search Partnering Companies

2020 BIO Digital Thought Leaders

 

All Speakers
By Count | Alphabetical
  • Show All
By Count | Alphabetical
  • Show All
By Count | Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
photo
Wooyeol Baek
CEO, PLCOSKIN INC.
PLCOSKIN Inc.
Seoul, Korea, Republic of
photo
Christopher Bahl, MS, PhD
HEAD OF PROTEIN DESIGN, INSTITUTE FOR PROTEIN INNOVATION
Institute for Protein Innovation
Boston, Massachusetts, United States
photo
Rebecca Baker, PhD
DIRECTOR, HELPING TO END ADDICTION LONG-TERM (HEAL) INITIATIVE, NATIONAL INSTITUTES OF HEALTH
Disruptive Thinking: What's Next for Pain
United States
photo
Cheryl Baker, PhD
SCIENTIFIC FOUNDER AND CHIEF SCIENTIFIC RESEARCH OFFICER, BIOCURITY PHARMACEUTICALS INC.
BioCurity Pharmaceuticals Inc.
Jupiter, Florida, United States
photo
David Baker
CEO, VALLON PHARMACEUTICALS
Vallon Pharmaceuticals
Philadelphia, Pennsylvania, United States
photo
Sasha Bakhru, PhD
PRESIDENT & CHIEF EXECUTIVE OFFICER, PEROSPHERE TECHNOLOGIES
Addressing the Unmet Need in Cardiovascular Disease Development
United States
photo
Stéphane Bancel
CHIEF EXECUTIVE OFFICER, MODERNA THERAPEUTICS, INC
A Way Forward: Winning the War on COVID through Vaccines
Cambridge, Massachusetts, United States
photo
Jianxin Bao
CEO, GATEWAY BIOTECHNOLOGY, INC.
Gateway Biotechnology Inc.
Kent, Ohio, United States
photo
Erica Barnes
EXECUTIVE DIRECTOR, MINNESOTA RARE DISEASE ADVISORY COUNCIL
Gene Therapy: The Long Horizon and Broad Challenges
Saint Paul, Minnesota, United States
photo
Jenny Barnett
CEO, MONUMENT TX
Digital Biomarkers: A New Dawn in CNS R&D
Cambridge, United Kingdom
photo
Dror Bashan
CEO, PROTALIX BIOTHERAPEUTICS
Protalix BioTherapeutics
Carmiel, Israel
photo
Ken Batchelor, PhD
CEO, NOVATARG THERAPEUTICS
NovaTarg Therapeutics
Research Triangle Park, North Carolina, United States
photo
Alison Bateman-House, MPH, PhD, MA
ASSISTANT PROFESSOR, DIVISION OF MEDICAL ETHICS, NYU GROSSMAN SCHOOL OF MEDICINE
Bioethics Through the Lens of a Pandemic
New York, New York, United States
photo
Steve Bates
CHIEF EXECUTIVE OFFICER, UK BIOINDUSTRY ASSOCIATION (BIA)
International Plenary Session: How are Global Leaders Collaborating to Combat the Pandemic?
London, United Kingdom
photo
Bruce Bauer, PhD
CEO, TAE LIFE SCIENCES
TAE Life Sciences
Foothill Ranch, California, United States
photo
Jake Bauer
CHIEF BUSINESS OFFICER, MYOKARDIA
Precision Medicine Outside Oncology: One Size Does Not Fit All
San Francisco, California, United States
photo
Shannon Baumann
SENIOR DIRECTOR, ACCESS VALUE AND EVIDENCE STRATEGY, BLUEBIRD BIO
Precision financing for Durable/curative Therapies
photo
Susan Baxter, PhD
EXECUTIVE DIRECTOR, CALIFORNIA STATE UNIVERSITY PROGRAM FOR EDUCATION AND RESEARCH IN BIOTECHNOLOGY
Diversity and Inclusion in the Bio-innovation Ecosystem
San Diego, California, United States
photo
Mandy Bazile
DIRECTOR, GOVERNMENT AFFAIRS, PUBLIC POLICY & REIMBURSEMENT, GENENTECH
Access to Personalized Medicine Drives Utilization of Genomic Tests and Targeted Therapies
photo
Yvan Beaudoin
CEO, THORASYS
Thorasys
Montreal, Quebec, Canada
photo
Dirk Beelen
DIRECTOR , HEALTH AND MEDICAL INDUSTRIES SOUTH AUSTRALIA
Health and Medical Industries South Australia
Adelaide, Australia
photo
Sue Behrens, PhD
RATHMANN PROFESSOR IN BIOPROCESSING AND DIRECTOR OF THE AMGEN BIOPROCESSING CENTER, KECK GRADUATE INSTITUTE
Discover/Develop: But How Will you Manufacture Your Therapeutic?
Claremont, California, United States
photo
Piraye Beim
CEO, CELMATIX
Celmatix
New York, New York, United States
photo
Ksenia Belkina
CEO, CARDIOMO CARE, INC.
Cardiomo Care, Inc.
New York, New York, United States
photo
Marc L. Belsky
CHIEF FINANCIAL OFFICER AND SECRETARY, KEZAR LIFE SCIENCES
Federal Economic Recovery Efforts for Small Biotechnology Companies
South San Francisco, California, United States
photo
Rahima Benhabbour
FOUNDER & DIRECTOR, ANELLEO, INC.
Anelleo, Inc.
Chapel Hill, North Carolina, United States
photo
Richard Berenson
CHIEF EXECUTIVE OFFICER, THERMALIN INC.
Thermalin Inc.
Waban, Massachusetts, United States
photo
Fabian Berkemeier
DIRECTOR, VALUE AND ACCESS STRATEGY, IGES INSTITUT GMBH
How will healthcare systems adapt to the Post-COVID-19 World?
Berlin, Germany
photo
Seth Berkley
CEO, GAVI, THE VACCINE ALLIANCE
A Way Forward: Winning the War on COVID through Vaccines
New York, New York, United States
photo
Jeff Berkowitz, JD
CEO AND DIRECTOR, REAL ENDPOINTS
Rare Disease Therapies are No Longer Rare: Can the US Healthcare Reimbursement System Handle Chronic Treatments for Orphan Diseases
New Jersey, United States
photo
Sylvain Berlemont
CEO, KEEN EYE
KEEN EYE
Paris, France
photo
Arnaud Bernaert
HEAD OF HEALTH AND HEALTHCARE, MEMBER OF THE EXECUTIVE COMMITTEE, WORLD ECONOMIC FORUM
Reinventing Partnerships to Deliver Value for Patients & Society
cologny, Switzerland
photo
Brian Berridge, PhD
ASSOCIATE DIRECTOR, NATIONAL TOXICOLOGY PROGRAM; SCIENTIFIC DIRECTOR, DIVISION OF NTP, NIH
Organs-on-a-Chip and AI: Realizing Potential Efficiencies in Drug Discovery and Development
United States
photo
Gordon Bethwaite
ACTING CEO, NOVAI
Novai
San Diego, California, United States
photo
Ami Bhatt
ASSISTANT PROFESSOR, MEDICINE-HEMATOLOGY AND GENETICS, STANFORD UNIVERSITY
Next Generation Advances in Human Microbiome Research
Stanford, California, United States
photo
Indu Bhushan
CEO AYUSHMAN BHARAT & NATIONAL HEALTH AUTHORITY, GOVERNMENT OF INDIA
The Lure of Universal Healthcare ! What India is doing in Healthcare
New Delhi, India
photo
Barbara Bierer, MD
FACULTY DIRECTOR, MULTI-REGIONAL CLINICAL TRIALS CENTER OF BRIGHAM AND WOMEN'S HOSPITAL AND HARVARD
Including the Patient Voice to Advance Diversity and Support Clear Communications
Cambridge, Massachusetts, United States
photo
Igor Bilinsky
CHIEF BUSINESS OFFICER, ONCTERNAL THERAPEUTICS
Oncternal Therapeutics
San Diego, California, United States
photo
Louise Binder
HEALTH POLICY CONSULTANT, SAVE YOUR SKIN FOUNDATION
Closing the Gap Between Regulatory Approval and Public Pricing/Listing of Innovative BioPharmaceuticals
photo
Paul Biondi
EXECUTIVE PARTNER, FLAGSHIP PIONEERING
Getting a seat at the table: how can new small companies enter the oncology space?
Princeton, New Jersey, United States
photo
Lars Birgerson, MD, PhD
PRESIDENT & CEO, ADLAI NORTYE USA INC.
Adlai Nortye USA Inc
North Brunswick, New Jersey, United States
photo
Teresa Bitetti
PRESIDENT, GLOBAL ONCOLOGY, TAKEDA
What Was Hot at ASCO 2020? Highlights from the World’s Biggest Oncology Meeting
photo
Fritz Bittenbender
SENIOR VICE PRESIDENT, GOVERNMENT AFFAIRS, GENENTECH, A MEMBER OF THE ROCHE GROUP
In an Era of Partisan Stalemate, What Drug Pricing Policies Can the Executive Branch Enact Without Congressional Authority?
Washington, United States
photo
Clare Blain
CEO, LIFE SCIENCES QUEENSLAND LIMITED
Queensland, Australia - Global Innovation Hub
Brisbane, Australia
photo
Leah Bloom, PhD
SENIOR VICE PRESIDENT, EXTERNAL INNOVATION AND STRATEGIC ALLIANCES, AVEXIS, A NOVARTIS COMPANY
AveXis, Inc., a Novartis Company
Bannockburn, Illinois, United States
photo
Vincent Blouin, BSc, MBA
CHIEF MARKETING OFFICER, RASPBERRY SCIENTIFIC INC.
Raspberry Scientific Inc.
Magog, Quebec, Canada
photo
Ken Blount, PhD
CHIEF SCIENTIFIC OFFICER, REBIOTIX
Keys to the Cure: Will the Microbiome Live Up to the Hype?
United States
photo
Jeffrey Blue
DIRECTOR OF VACCINE DRUG PRODUCT DEVELOPMENT AND NEW TECHNOLOGIES, MERCK & CO.
Beyond the Needle: Novel Approaches to Vaccine Delivery
photo
Jeffrey Bockman, PhD
EVP, ONCOLOGY PRACTICE HEAD, CELLO HEALTH BIOCONSULTING (PREVIOUSLY DEFINED HEALTH)
Future of IO Checkpoint Combinations
United States
photo
Sierra Bodor, BS
PUBLIC HEALTH PROGRAM MANAGER, HEPATITIS B FOUNDATION
Developing a New Rare Disease Diagnostic: From Fueling Clinical Trials to Building a Market
Doylestown, Pennsylvania, United States
photo
Natasha Bonhomme
CHIEF STRATEGY OFFICER, GENETIC ALLIANCE
Next Generation Orphan Drug Incentives
Washington, United States
photo
Aarash Bordbar, PhD
CO-FOUNDER & CTO, SINOPIA BIOSCIENCES, INC.
Sinopia Biosciences, Inc.
San Diego, California, United States
photo
Christophe Bourdon
VICE PRESIDENT AND GENERAL MANGER, ONCOLOGY (US OPERATIONS), AMGEN INC.
International Plenary Session: How are Global Leaders Collaborating to Combat the Pandemic?
Vienna, Austria
photo
Terry Bowlin
PRESIDENT & CEO, MICROBIOTIX, INC.
Microbiotix, Inc.
Worcester, Massachusetts, United States
photo
Matt Bradley, PhD
CHAIRMAN, PRESIDENT, FOUNDER, SAJE PHARMA, LLC
SAJE Pharma, LLC
Kalispell, Montana, United States
photo
Kerrie Brady, Bpharm, MBA, MSc
CO-FOUNDER AND FORMER CBO CENTREXION
Demystifying buzzwords – How AI and machine learning are being used NOW in the life sciences
United States
photo
Kimberly Brandt
PRINCIPAL DEPUTY ADMINISTRATOR FOR POLICY & OPERATIONS, CENTERS FOR MEDICAID & MEDICARE SERVICES
Disruptive Thinking: What's Next for Pain
Baltimore, Maryland, United States
photo
Joel Braunstein, MBA, MD
CEO, C2N DIAGNOSTICS, LLC
Brave Innovations: Public and Private Solutions to Advance Alzheimer’s Therapeutics and Diagnostic in a Risk-Averse Climate
St. Louis, Missouri, United States
photo
Graham Brearley
GENERAL MANAGER, MADISON, CATALENT BIOLOGICS
How COVID-19 Is Reshaping Vaccine Development: Innovations in Vaccine Technology and Manufacturing Partnerships
photo
Isaac Bright
CEO, RUBRYC THERAPEUTICS, INC.
RubrYc Therapeutics, Inc.
San Carlos, California, United States
photo
Alex Brill
RESIDENT FELLOW, AMERICAN ENTERPRISE INSTITUTE
How can the U.S. cultivate a strong and competitive biosimilars market?
Washington, District Of Columbia, United States
photo
Remy Brim, PhD
VICE PRESIDENT REGULATORY POLICY AND STRATEGY, BGR GOVERNMENT AFFAIRS
In an Era of Partisan Stalemate, What Drug Pricing Policies Can the Executive Branch Enact Without Congressional Authority?
Washington, District Of Columbia, United States
photo
Nicholas Brooke
EXECUTIVE DIRECTOR, PATIENT FOCUSED MEDICINES DEVELOPMENT
Global Patient Advocacy in the COVID Era: What Is the Future of Patient Advocacy around the World?
Brussels,
photo
Jason Brown, PhD
CHIEF BUSINESS OFFICER, EVEREST MEDICINES
Licensing Clinical-Stage Assets to Greater China
San Diego, California, United States
photo
Nick Brown
NORTH AMERICAN BUSINESS DEVELOPMENT MANAGER, RETROGENIX LIMITED
Retrogenix Limited
Chinley, High Peak, United Kingdom
photo
Shane Brown
DIRECTOR BUSINESS DEVELOPMENT – WESTERN NORTH AMERICA , OLON RICERCA BIOSCIENCE LLC
Olon S.p.A
Concord, Ohio, United States
photo
Ronan Brown
SENIOR VP & HEAD, INTEGRATED GLOBAL COMPLIANCE, IQVIA, IQVIA
IQVIA
San Diego, California, United States
photo
Wilson Bryan, MD
DIRECTOR, OFFICE OF TISSUES AND ADVANCED THERAPIES, FDA
Race Against the Clock: Bringing New Cell and Gene Therapies to Market
White Oak, Maryland, United States
photo
Matt Bryant, PharmD
VP, GLOBAL MEDICAL AFFAIRS, EIGER BIOPHARMACEUTICALS
Developing a New Rare Disease Diagnostic: From Fueling Clinical Trials to Building a Market
Palo Alto, California, United States
photo
John Bucksath
CHIEF EXECUTIVE OFFICER AND BOARD MEMBER, KCAS, LLC
Bioscience Professional Toolkit - How to successfully transition to a post-academic career
Shawnee Mission, Kansas, United States
photo
Sanjay Budhdeo, MD
BUSINESS DEV. DIRECTOR, OWKIN
Can AI Prevent Epidemics?
photo
Hugues Bultot
CEO, EXOTHERA
Exothera
Brussels, Belgium
photo
TIMOTHY BURLAND, BSc, PhD
DIRECTOR OF BUSINESS DEVELOPMENT, SCARAB GENOMICS LLC
Scarab Genomics
Wisconsin, United States
photo
Stephen Byers
PROFESSOR OF ONCOLOGY, DIRECTOR, GUMC SHARED RESOURCES , DIVINER THERAPEUTICS LLC
Diviner Therapeutics LLC
Washington, District Of Columbia, United States
photo
Jeff Bylund, PhD
APPLICATIONS MANAGER, NIKON INSTRUMENTS
Nikon BioImaging Lab
Melville, New York, United States
Load More